National Cancer Institute  www.cancer.gov  U.S. National Institutes of Health
 


Cancer Trends Progress Report – 2009/2010 Update

Skip to content
Progress Report  Home

Progress Report Tools
 Print this page
 Generate custom report



In the Report
Introduction
Trends-at-a-Glance
Summary Tables
Prevention
Early Detection
Diagnosis
Treatment
> Bladder Cancer Treatment
Breast Cancer Treatment
Colorectal Cancer Treatment
Kidney Cancer Treatment
Lung Cancer Treatment
Ovarian Cancer Treatment
Prostate Cancer Treatment
Life After Cancer
End of Life



Bladder Cancer Treatment
Treatment

There has been a significant increase in the use of intravesical therapy for patients diagnosed with non-muscle invasive Ta G1-2 bladder cancer. However, this therapy is given to only 27 percent of patients with non-muscle invasive disease.

On this page:

Benefits of Treatment

The use of intravesical therapy has been associated with improved survival.

Back to Top

Measure

Percentage of individuals receiving intravesical therapy in non-muscle invasive bladder cancer.

Back to Top

Period – 1995–2003

Back to Top

Trends – Rising in Ta G1-2; stable in other non-muscle invasive disease.

Back to Top

Most Recent Estimates

In 2003, 27 percent of patients with non-muscle invasive disease received intravesical therapy.

Back to Top

Healthy People 2010 Targets

There are no Healthy People 2010 targets for bladder cancer treatment.

Back to Top

Groups at High Risk for Not Receiving Appropriate Treatment

The use of intravesical therapy varies by geographic area, with individuals in the mid-West more likely to receive intravesical therapy compared to those living in Los Angeles. Patients of other races, primarily Asians, were more likely to receive intravesical therapy than White patients. There were no differences between White, Black, and Hispanic patients in the use of intravesical therapy.

Back to Top

Key Issues

The barriers to the use of intravesical therapy should be identified.

Back to Top

Additional Information on Bladder Cancer Treatment

Back to Top

Back: Treatment

National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthUSA.gov